A number of firms have modified their ratings and price targets on shares of West Pharmaceutical Services (NYSE: WST) recently:
- 8/12/2026 – West Pharmaceutical Services was downgraded by Zacks Research from “strong-buy” to “hold”.
- 8/7/2026 – West Pharmaceutical Services was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
- 8/3/2026 – West Pharmaceutical Services had its price target raised by Citigroup Inc. from $400.00 to $412.00. They now have a “buy” rating on the stock.
- 7/27/2026 – West Pharmaceutical Services had its “outperform” rating reaffirmed by Evercore Inc. They now have a $425.00 price target on the stock.
- 7/24/2026 – West Pharmaceutical Services had its “hold (c)” rating reaffirmed by Weiss Ratings.
- 7/15/2026 – West Pharmaceutical Services had its “buy” rating reaffirmed by TD Cowen.
- 7/13/2026 – West Pharmaceutical Services is now covered by BNP Paribas Exane. They set an “outperform” rating and a $447.00 price target on the stock.
- 7/9/2026 – West Pharmaceutical Services had its price target raised by Morgan Stanley from $325.00 to $365.00. They now have an “equal weight” rating on the stock.
- 7/6/2026 – West Pharmaceutical Services had its “outperform” rating reaffirmed by Evercore Inc. They now have a $410.00 price target on the stock.
- 7/2/2026 – West Pharmaceutical Services had its price target raised by KeyCorp from $350.00 to $390.00. They now have an “overweight” rating on the stock.
West Pharmaceutical Services Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 5th. Shareholders of record on Wednesday, July 29th were paid a dividend of $0.22 per share. The ex-dividend date of this dividend was Wednesday, July 29th. This represents a $0.88 annualized dividend and a yield of 0.3%. West Pharmaceutical Services’s dividend payout ratio is currently 11.27%.
In addition to component manufacturing, West provides engineered delivery systems and support services across the product lifecycle.
Featured Stories
- Five stocks we like better than West Pharmaceutical Services
- JFrog’s AI Opportunity Could Fuel a Big Leap in Share Price
- Is SiTime the Best AI Stock You’ve Never Heard Of?
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
Receive News & Ratings for West Pharmaceutical Services Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc and related companies with MarketBeat.com's FREE daily email newsletter.
